Here are five quick facts:
1. Stephens has an “overweight” rating on AmSurg stock.
2. The firm’s price objective indicates a possible upside of 18.41 percent from AmSurg’s current price objective.
3. On Monday, AmSurg shares traded down nearly 0.3 percent, hitting $81.92.
4. AmSurg’s market cap is $3.91 billion.
5. The P/E ratio is 33.85.
More articles on surgery centers:
3 new joint venture ASCs — November 2015
Health Republic insurance closure affects 200k people — 4 observations
NY DOH issues final approval for Orchard Park ASC
